default author photo

Chun Chen

Fujian Medical University - Union Hospital

Fuzhou, Fujian 350001

China

SCHOLARLY PAPERS

1

DOWNLOADS

43

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Genomic Signature for Personalized Adjuvant Therapy in Resected EGFR-Mutant Stage II-III Non-Small Cell Lung Cancer: Results from Phase 3 ADJVANT/CTONG1104 Study

Number of pages: 30 Posted: 28 Oct 2020
Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Geneseeq Technology Inc. - Nanjing Geneseeq Technology Inc., Fudan University - Zhongshan Hospital, Chinese Academy of Sciences (CAS) - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Geneseeq Technology Inc. - Nanjing Geneseeq Technology Inc., Geneseeq Technology Inc. - Nanjing Geneseeq Technology Inc., Central South University - Hunan Cancer Hospital, Fujian Medical University - Union Hospital, Jilin Provincial Cancer Hospital, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Geneseeq Technology Inc. - Nanjing Geneseeq Technology Inc., Geneseeq Technology Inc. - Geneseeq Research Institute, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute and Southern Medical University
Downloads 43 (1,157,785)
Citation 1

Abstract:

Loading...

Adjuvant therapy, EGFR, TKI, chemotherapy, non-small cell lung cancer